Back to Journals » Drug Design, Development and Therapy » Volume 16

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

Total article views   HTML views PDF downloads Totals
12,338 Dovepress* 8,362+ 270 8,632
PubMed Central* 3,976 843 4,819
Totals 12,338 1,113 13,451
*Since 2 September 2022
Total mentioned Facebook Delicious Reddit Twitter Others
17 0 0 0 7 10

View citations on PubMed Central and Google Scholar